Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Go back to Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years| (NASDAQ: BNTX) | Delayed: 96.90 +2.98 (3.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.92 | 52 Week High | $ | |||
| Open | $94.49 | 52 Week Low | $ | |||
| Day High | $96.90 | P/E | N/A | |||
| Day Low | $94.49 | EPS | $ | |||
| Volume | 124,020 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.33 +0.45 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.88 | 52 Week High | $37.39 | |||
| Open | $24.15 | 52 Week Low | $28.25 | |||
| Day High | $24.40 | P/E | 14.75 | |||
| Day Low | $24.13 | EPS | $1.65 | |||
| Volume | 6,310,656 | |||||
